cyclosporine has been researched along with Pterygium in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arruda, GV; Fonseca, EC; Rocha, EM | 1 |
| Bao, N; Liang, K; Tao, L; Zhang, Q | 1 |
| Meneghim, RLFS; Natsuaki, KL; Oliveira, AC; Padovani, CR; Satto, LH; Schellini, SA; Viveiros, MMH | 1 |
| Jung, JC; Jung, SY; Kim, YH; Kim, YI; Lee, KW; Park, YJ | 1 |
| Candeias, JM; Hércules, LA; Kakizaki, FY; Padovani, CR; Schellini, SA; Viveiros, MM | 1 |
| Choi, S; Hwang, S | 1 |
| Gum, SI; Jung, JC; Kim, IG; Kim, YH; Lee, JS; Lee, KW; Park, YJ | 1 |
| Gum, SI; Jung, JC; Kim, YH; Kim, YI; Lee, KW; Ma, JY; Park, SB; Park, YJ | 1 |
| Akbas Kocaoglu, F; Burcu Nurozler, A; Duman, S; Ergun, G; Yalcin Tok, O | 1 |
| Aydin, A; Aykan, U; Bilge, AH; Can, G; Colakoglu, K; Karadayi, K | 1 |
| Ayar, O; Hasiripi, H; Koç, M; Özülken, K | 1 |
| Chen, G; Wu, H | 1 |
| Chou, TY; Donnenfeld, ED; Perry, HD; Solomon, R | 1 |
2 review(s) available for cyclosporine and Pterygium
| Article | Year |
|---|---|
Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.
Topics: Adjuvants, Immunologic; Alkylating Agents; Chemotherapy, Adjuvant; Conjunctiva; Cyclosporine; Fluorouracil; Humans; Immunosuppressive Agents; Mitomycin; Network Meta-Analysis; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pterygium; Randomized Controlled Trials as Topic; Recurrence; Transplantation, Autologous | 2018 |
Adjuvant Use of Cyclosporine A in the Treatment of Primary Pterygium: A Systematic Review and Meta-Analysis.
Topics: Conjunctiva; Cyclosporine; Humans; Immunosuppressive Agents; Pterygium; Transplantation, Autologous | 2018 |
4 trial(s) available for cyclosporine and Pterygium
| Article | Year |
|---|---|
Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence.
Topics: Adult; Combined Modality Therapy; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Postoperative Care; Preoperative Care; Prospective Studies; Pterygium; Recurrence; Surgical Flaps; Young Adult | 2019 |
A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Cell Count; Combined Modality Therapy; Cyclosporine; Double-Blind Method; Endothelium, Corneal; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mitomycin; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Prospective Studies; Pterygium; Recurrence; Vascular Endothelial Growth Factor A | 2015 |
Topical cyclosporine A in the prevention of pterygium recurrence.
Topics: Administration, Topical; Aged; Aged, 80 and over; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pterygium; Recurrence; Retrospective Studies; Turkey | 2008 |
[Effectiveness of topical ciclosporin A treatment after excision of primary pterygium and limbal conjunctival autograft].
Topics: Administration, Topical; Adolescent; Adult; Cicatrix; Corneal Transplantation; Cyclosporine; Female; Granuloma; Humans; Immunosuppressive Agents; Limbus Corneae; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Postoperative Complications; Prospective Studies; Pterygium; Recurrence; Transplantation, Autologous; Young Adult | 2008 |
7 other study(ies) available for cyclosporine and Pterygium
| Article | Year |
|---|---|
Cyclosporine A Downregulates MMP-3 and MMP-13 Expression in Cultured Pterygium Fibroblasts.
Topics: Blotting, Western; Cell Movement; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Female; Fibroblasts; Gene Expression Regulation; Humans; Immunosuppressive Agents; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Pterygium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2015 |
In vitro study of cyclosporine A 0.05 % on primary and recurrent pterygium fibroblasts.
Topics: Analysis of Variance; Cell Count; Cell Proliferation; Cyclosporine; Fibroblasts; Humans; Immunosuppressive Agents; Prospective Studies; Pterygium | 2016 |
Cyclosporine A inhibits TGF-β2-induced myofibroblasts of primary cultured human pterygium fibroblasts.
Topics: Actins; Cell Differentiation; Cells, Cultured; Cyclosporine; Female; Fibroblasts; Fibronectins; Humans; Immunosuppressive Agents; Inflammation; Laminin; Male; Microscopy, Fluorescence; Muscle, Smooth; Myofibroblasts; Oligonucleotides; Pterygium; Signal Transduction; Software; Transforming Growth Factor beta2 | 2017 |
Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.
Topics: Bevacizumab; Cell Movement; Cyclosporine; Down-Regulation; Female; Fibroblasts; Gene Expression Regulation; Humans; Immunohistochemistry; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Pterygium | 2017 |
Topical cyclosporine A administration after pterygium surgery.
Topics: Administration, Topical; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Postoperative Period; Pterygium; Secondary Prevention; Surgical Flaps; Treatment Outcome | 2012 |
[Cyclosporine A and thiotepa in prevention of postoperative recurrence of pterygium].
Topics: Adult; Aged; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Postoperative Care; Pterygium; Secondary Prevention; Thiotepa | 1999 |
Resolution of scleromalacia.
Topics: Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lacrimal Apparatus; Middle Aged; Postoperative Complications; Prosthesis Implantation; Pterygium; Scleral Diseases | 2007 |